Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
antiviral drug
|
| gptkbp:approvalYear |
1996
|
| gptkbp:ATCCode |
J05AB12
|
| gptkbp:CASNumber |
113852-37-2
|
| gptkbp:chemicalFormula |
C8H14N3O6P
|
| gptkbp:contraindication |
renal impairment
|
| gptkbp:eliminationHalfLife |
2.6 hours
|
| gptkbp:excretion |
renal
|
| gptkbp:genericName |
gptkb:cidofovir
|
| https://www.w3.org/2000/01/rdf-schema#label |
Vistide
|
| gptkbp:indication |
AIDS-related CMV retinitis
|
| gptkbp:KEGGID |
D00295
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Gilead_Sciences
|
| gptkbp:mechanismOfAction |
inhibits viral DNA polymerase
|
| gptkbp:MeSH_ID |
D019380
|
| gptkbp:metabolism |
not significantly metabolized
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:PubChem_CID |
60621
CHEMBL1425 DB00523 |
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
nephrotoxicity
neutropenia ocular hypotony |
| gptkbp:UNII |
8T49QOQ44I
|
| gptkbp:usedFor |
cytomegalovirus retinitis
|
| gptkbp:bfsParent |
gptkb:cidofovir
|
| gptkbp:bfsLayer |
7
|